King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating to the sale and licence of the rights to Seroquel...

09 May 2018

These representations earned the Kyrgyz Republic a win in an investment treaty interpretation case named by Global Arbitration Review as among the ten 'most important decisions' of 2014 globally.

28 March 2018

King & Wood Mallesons represented NextView Capital, a leading Chinese institutional fund management group focused on new technologies and energy in its acquisition of a 19.89% equity interest in...

18 December 2017

King & Wood Mallesons has improved its overall position in the 2017 Acritas Global Elite Law Firm Brand Index, ranking 13th.

12 October 2017